Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units
- PMID: 23880286
- DOI: 10.1016/j.actatropica.2013.07.003
Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units
Abstract
A total of 221 children from two rural settlements in Northeast Argentina were examined for T. cruzi infection. Blood samples were taken for serology tests and PCR assays. In addition, T. cruzi Discrete Typing Units (DTUs) were determined by hybridization with specific DNA probes of the minicircle hypervariable regions (mHVR). Serological results indicated that 26% (57/215) were reactive against T. cruzi antigens. PCR analyses were performed on seropositive samples showing presence of parasite DNA in 31 out of 53 samples (58.5%). All seropositive children underwent specific chemotherapy with Benznidazole (5mg/kg/day) for a period of two months and were monitored two and five years after treatment. Overall the treatment was well tolerated and low side effects were observed. Serological conversion was observed at two years post -treatment in one child form Pampa Ávila and at five years in two children from Tres Estacas. However, at the end of the follow-up period, T. cruzi DNA could not be detected by PCR in samples from treated children, except in two cases. In addition, the results of hybridizations with specific DNA probes showed that DTU TcV was detected in 68% (21/31), TcVI in 7% (2/31) and TcV/VI in 3% (1/31) of the samples. Altogether, results of the follow-up of treated children showed a low rate of seroconversion; however trend toward seroconversion was evident at five years post-treatment. On the other hand, detection of T. cruzi DNA by PCR significantly decreased after Benznidazole treatment. The existence of data regarding serological and molecular follow-ups from controlled studies in the Chaco Region will be important for future treatment efforts against T. cruzi infection in this region. The results obtained in the present study represent a contribution in this regard.
Keywords: Benznidazole; Chagas disease; DTUs; Hybridization; PCR; Serology.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Trypanosoma cruzi diversity in the Gran Chaco: mixed infections and differential host distribution of TcV and TcVI.Infect Genet Evol. 2015 Jan;29:53-9. doi: 10.1016/j.meegid.2014.11.001. Epub 2014 Nov 8. Infect Genet Evol. 2015. PMID: 25445658
-
Chagas' disease in Aboriginal and Creole communities from the Gran Chaco Region of Argentina: Seroprevalence and molecular parasitological characterization.Infect Genet Evol. 2016 Jul;41:84-92. doi: 10.1016/j.meegid.2016.03.028. Epub 2016 Apr 4. Infect Genet Evol. 2016. PMID: 27057620
-
Simple methodology to directly genotype Trypanosoma cruzi discrete typing units in single and mixed infections from human blood samples.Infect Genet Evol. 2016 Sep;43:123-9. doi: 10.1016/j.meegid.2016.05.026. Epub 2016 May 18. Infect Genet Evol. 2016. PMID: 27208806
-
Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.Acta Trop. 2018 Aug;184:38-52. doi: 10.1016/j.actatropica.2017.09.017. Epub 2017 Sep 21. Acta Trop. 2018. PMID: 28941731 Review.
-
Chagas disease and the US blood supply.Curr Opin Infect Dis. 2008 Oct;21(5):476-82. doi: 10.1097/QCO.0b013e32830ef5b6. Curr Opin Infect Dis. 2008. PMID: 18725796 Review.
Cited by
-
Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.PLoS One. 2015 Oct 5;10(10):e0139363. doi: 10.1371/journal.pone.0139363. eCollection 2015. PLoS One. 2015. PMID: 26436678 Free PMC article.
-
Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation.PLoS Negl Trop Dis. 2017 Feb 13;11(2):e0005336. doi: 10.1371/journal.pntd.0005336. eCollection 2017 Feb. PLoS Negl Trop Dis. 2017. PMID: 28192425 Free PMC article.
-
Chagas Disease in the United States: a Public Health Approach.Clin Microbiol Rev. 2019 Nov 27;33(1):e00023-19. doi: 10.1128/CMR.00023-19. Print 2019 Dec 18. Clin Microbiol Rev. 2019. PMID: 31776135 Free PMC article. Review.
-
Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis.Drug Saf. 2018 Nov;41(11):1035-1048. doi: 10.1007/s40264-018-0696-5. Drug Saf. 2018. PMID: 30006773
-
Elucidating diversity in the class composition of the minicircle hypervariable region of Trypanosoma cruzi: New perspectives on typing and kDNA inheritance.PLoS Negl Trop Dis. 2019 Jun 27;13(6):e0007536. doi: 10.1371/journal.pntd.0007536. eCollection 2019 Jun. PLoS Negl Trop Dis. 2019. PMID: 31247047 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical